Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TCA vs Tretinoin for Acanthosis Nigricans
NCT06008327Completed
- Sponsor
- Jinnah Postgraduate Medical Centre
- Start
- Aug 2022
- Primary completion
- Jun 2023
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
Trial of trichloroacetic acid in acanthosis nigricans (2 arms), sponsored by Jinnah Postgraduate Medical Centre. Primary endpoint: Efficacy of Topical 15% Trichloroacetic Acid Versus 0.05% Topical Tretinoin at 2 months. Started Aug 2022; status: completed.
02
Drugs
trichloroacetic acid
03
Conditions
acanthosis nigricans
Beyond the preview
Go deeper on NCT06008327.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06008327.